Neo-Adjuvant Treatment in Primary Resectable Pancreatic Cancer: A Systematic Review and PRISMA-Compliant Updated Metanalysis of Oncological Outcomes

SIMPLE SUMMARY: Pancreatic adenocarcinoma is the fourth leading cause of cancer-related death in industrialized countries. In locally advanced and borderline resectable pancreatic cancer, neoadjuvant therapy (NAT) has been shown to be effective in eliminating potentially circulating tumor cells and...

Descripción completa

Detalles Bibliográficos
Autores principales: Roesel, Raffaello, Deantonio, Letizia, Bernardi, Lorenzo, Garo, Maria Luisa, Majno-Hurst, Pietro, Vannelli, Alberto, Cefalì, Marco, Palmarocchi, Maria Celeste, Valli, Maria Carla, Pesola, Guido, Cristaudi, Alessandra, De Dosso, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526896/
https://www.ncbi.nlm.nih.gov/pubmed/37760596
http://dx.doi.org/10.3390/cancers15184627

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526896/
https://www.ncbi.nlm.nih.gov/pubmed/37760596
http://dx.doi.org/10.3390/cancers15184627

Ejemplares similares